T1	HMM 754 770	overall survival
T2	HMM 854 936	0.05], progression-free survival (PFS) and survival with a functional larynx (SFL)
T3	HMM 998 1025	patients, disease evolution
T4	HMM 1141 1160	The 10-year OS rate
T5	HMM 1225 1246	The 10-year PFS rates
T6	HMM 1307 1327	the 10-year SFL rate
T7	HMM 1371 1409	compromise disease control or survival
